Regulation of human PLC delta-1
US7049089B2 · kind B2 · utility
0Cited by
0References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 29, 2001 |
| Grant date | May 23, 2006 |
| Priority date | — |
| Expiry date | Oct 21, 2022 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Reagents which regulate human PLC delta-1 activity and reagents which bind to human PLC delta-1 gene products can be used, inter alia, to treat COPD, congestive heart failure, hypertension, and cancer, and a variety of conditions in which signal transduction is impaired.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.